Device Trial Radar · NCT07630064
Flo Digital Contraceptive Study
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
3,800
Planned (sponsor's estimate)
Start
Apr 22, 2026
Primary completion
Jan 10, 2028
Study completion Jan 10, 2028
Sponsor
- Lead sponsor
- Flo Health Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Exponent
- First posted
- Jun 5, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if the Flo Digital Contraceptive (FDC) app can effectively prevent unintended pregnancy in women aged 18 years and older residing in the United States. The main questions it aims to answer are: 1. What is the rate of unintended pregnancy in women aged 18-35 years using FDC as their sole method of contraception under typical-use conditions, measured using the Pearl Index? 2. What is the cumulative probability of unintended pregnancy over 13 menstrual cycles for all participants, including those with regular and irregular cycles? Participants will: * Use the Flo Digital Contraceptive app in 'prevent pregnancy' mode as their primary method of contraception for up to 13 menstrual cycles or 18 months, whichever comes first * Wear an Apple Watch (Series 8 or later, or Ultra or SE3) while sleeping to collect nightly wrist temperature data, which the app uses to detect ovulation * Log menstrual cycles, sexual activity, and any use of emergency contraception directly in the Flo app * Complete monthly electronic surveys (ePROs) administered by the study team covering pregnancy status, adherence, safety, and experience * Complete a baseline demographic survey at enrollment and an exit survey at the end of participation
Conditions
- Contraception Use
Interventions
Flo Digital ContraceptiveDevice
The Flo Digital Contraceptive (FDC) is a fertility awareness-based Software as a Medical Device (SaMD) integrated within the Flo Period \& Cycles Tracker app (iOS) in 'prevent pregnancy' mode. The FDC uses a proprietary machine-learning algorithm to classify each day of the user's menstrual cycle as either 'Not fertile' (unprotected intercourse permitted) or 'Use protection' (abstinence or barrier contraception required). Classifications are generated dynamically using menstrual cycle history and overnight wrist-skin temperature measured via Apple Watch (Series 8 or later, or Ultra), synchronized daily through Apple Health, with optional urinary LH test results as a supplementary input. Participants use FDC as their sole method of contraception for up to 13 menstrual cycles or 18 months from device activation, whichever occurs first.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Typical-Use Pearl Index in Women Aged 18-35 Years with Regular Menstrual CyclesTime frame: Up to 13 menstrual cycles or 18 months from FDC activation, whichever occurs first.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Exponent
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.